Mitesh

Community Pharmacy England on behalf of pharmacy owners (our members) made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 9 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2023. This takes [...]

The post 9 products added to the Discount Not Deducted (DND) list from October 2023 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Utrogestan® 100mg capsules are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP056 Utrogestan® 100mg capsules expires at 23.59pm on Friday 29 September 2023. After this date, any prescriptions for Utrogestan® 100mg capsules must be dispensed [...]

The post Expiry of SSP056 Utrogestan® 100mg capsules appeared first on Community Pharmacy England.

The October 2023 Drug Tariff has been updated to include a deadline for submission of any outstanding referred back prescriptions to the NHS Business Services Authority (NHSBSA) for payment. All prescriptions that have been referred-back must be completed and returned to the NHSBSA no later than 18 months from the date they are first sent [...]

The post Deadline for submission of outstanding referred back prescriptions appeared first on Community Pharmacy England.

A disallowed item is one that has NOT been passed for payment by the NHS Business Services Authority (NHSBSA). Please check your disallowed items history on Manage Your Service (MYS) portal to identify the list of unpaid items and reasons why the item was disallowed by the NHSBSA. If you believe an item has been [...]

The post Check and challenge your disallowed items using MYS appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 1 August 2023) has been published and includes articles on: Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions Valproate: re-analysis [...]

The post MHRA Drug Safety Update August 2023 appeared first on Community Pharmacy England.